Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccine

Clinical and Vaccine Immunology

Volumn 16, Issue 1, 2009, Pages 78-87

  Saxena, Manvendra ^a   Coloe, Peter J ^a   Smooker, Peter M ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OVALBUMIN; PLASMID DNA; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; DRUG RESPONSE; FEMALE; GENE NUMBER; HUMORAL IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; FEMALE; GENE DOSAGE; GENE EXPRESSION; MACROPHAGES; MICE; MICE, INBRED BALB C; OVALBUMIN; PROMOTER REGIONS, GENETIC; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; T-LYMPHOCYTES; VACCINES, ATTENUATED;

EID: 58149376074     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00253-08     Document Type: Article

References (63)

1. Alderton, M. R., K. J. Fahey, and P. J. Coloe. 1991. Humoral responses and salmonellosis protection in chickens given a vitamin-dependent Salmonella typhimurium mutant. Avian Dis. 35:435-442.
2. al-Ramadi, B. K., M. J. Fernandez-Cabezudo, A. Ullah, H. El-Hasasna, and R. A. Flavell. 2006. CD154 is essential for protective immunity in experimental salmonella infection: evidence for a dual role in innate and adaptive immune responses. J. Immunol. 176:496-506.
3. Angelakopoulos, H., and E. L. Hohmann. 2000. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immun. 68:2135-2141.
4. Ashby, D., I. Leduc, W. Lauzon, B. Craig Lee, N. Singhal, and D. W. Cameron. 2005. Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. J. Immunol. Methods 299:153-164.
5. Atkins, H. S., M. Morton, K. F. Griffin, M. G. Stokes, J. P. Nataro, and R. W. Titball. 2006. Recombinant Salmonella vaccines for biodefence. Vaccine 24:2710-2717.
6. Attridge, S. R., R. Davies, and J. T. LaBrooy. 1997. Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain. Vaccine 15:155-162.
7. Attridge, S. R., and C. J. Vindurampulle. 2005. Vector-primed mice display hypo-responsiveness to foreign antigen presented by recombinant Salmonella regardless of the route of delivery. Microb. Pathog. 39:1-7.
8. Bachtiar, E. W., K. C. Sheng, T. Fifis, A. Gamvrellis, M. Plebanski, P. J. Coloe, and P. M. Smooker. 2003. Delivery of a heterologous antigen by a registered Salmonella vaccine (STM1). FEMS Microbiol. Lett. 227:211-217.
9. Bao, J. X., and J. D. Clements. 1991. Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect. Immun. 59:3841-3845.
10. Basso, H., M. Rohde, and C. A. Guzman. 2000. Vectors to achieve selective expression of vaccine antigens within eukaryotic cells using Salmonella spp. as carrier strains. FEMS Microbiol. Lett. 182:219-223.
11. Baud, D., J. Benyacoub, V. Revaz, M. Kok, F. Ponci, M. Bobst, R. Curtiss III, P. De Grandi, and D. Nardelli-Haefliger. 2004. Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium. Infect. Immun. 72:750-756.
12. Bondarenko, V. M., V. A. Beliavskaia, and A. A. Vorob'ev. 2002. Use of recombinant Salmonella strains for supplying the macro-organism with biologically active molecules. Zh. Mikrobiol. Epidemiol. Immunobiol. 2002:70-79. (In Russian.)
13. Bowe, F., D. J. Pickard, R. J. Anderson, P. Londono-Arcila, and G. Dougan. 2003. Development of attenuated Salmonella strains that express heterologous antigens. Methods Mol. Med. 87:83-100.
14. Boyle, J. S., C. Koniaras, and A. M. Lew. 1997. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 9:1897-1906.
15. Bullifent, H. L., K. F. Griffin, S. M. Jones, A. Yates, L. Harrington, and R. W. Titball. 2000. Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters. Vaccine 18:2668-2676.
16. +-T-cell responses. Infect. Immun. 69:7493-7500.
17. Capozzo, A. V., L. Cuberos, M. M. Levine, and M. F. Pasetti. 2004. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers. Infect. Immun. 72:4637-4646.
18. Cardenas, L., and J. D. Clements. 1993. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. Vaccine 11:126-135.
19. Catic, A., G. Dietrich, I. Gentschev, W. Goebel, S. H. Kaufmann, and J. Hess. 1999. Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages. Microbes Infect. 1:113-121.
20. Chabalgoity, J. A., C. M. Khan, A. A. Nash, and C. E. Hormaeche. 1996. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol. Microbiol. 19:791-801.
21. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology 10:888-892.
22. Chen, H., and D. M. Schifferli. 2001. Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector. Vaccine 19:3009-3018.
23. Chiu, C. H., C. Chu, C. C. He, and T. Y. Lin. 2006. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect. 8:1671-1678.
24. Cole, J. A. 1968. Cytochrome c552 and nitrite reduction in Escherichia coli. Biochim. Biophys. Acta 162:356-368.
25. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645.
26. Domenech, V. E., K. Panthel, K. M. Meinel, and H. Russmann. 2005. Rapid clearance of a recombinant Salmonella vaccine carrier prevents enhanced antigen-specific CD8 T-cell responses after oral boost immunizations. Microbes Infect. 7:860-866.
27. Dougan, G., C. E. Hormaeche, and D. J. Maskell. 1987. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system. Parasite Immunol. 9:151-160.
28. Dunstan, S. J., C. P. Simmons, and R. A. Strugnell. 2003. In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium. FEMS Immunol. Med. Microbiol. 37:111-119.
29. Dunstan, S. J., C. P. Simmons, and R. A. Strugnell. 1999. Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium. Infect. Immun. 67:5133-5141.
30. Everest, P., G. Frankel, J. Li, P. Lund, S. Chatfield, and G. Dougan. 1995. Expression of LacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: influence of growth in mammalian cells. FEMS Microbiol. Lett. 126:97-101.
31. Fayolle, C., A. Osickova, R. Osicka, T. Henry, M. J. Rojas, M. F. Saron, P. Sebo, and C. Leclerc. 2001. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity. J. Virol. 75:7330-7338.
32. Fouts, T. R., A. L. DeVico, D. Y. Onyabe, M. T. Shata, K. C. Bagley, G. K. Lewis, and D. M. Hone. 2003. Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1. FEMS Immunol. Med. Microbiol. 37:129-134.
33. Garmory, H. S., S. E. Leary, K. F. Griffin, E. D. Williamson, K. A. Brown, and R. W. Titball. 2003. The use of live attenuated bacteria as a delivery system for heterologous antigens. J. Drug Target. 11:471-479.
34. Hohmann, E. L., C. A. Oletta, W. P. Loomis, and S. I. Miller. 1995. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. USA 92:2904-2908.
35. Jayaraman, P. S., T. C. Peakman, S. J. Busby, R. V. Quincey, and J. A. Cole. 1987. Location and sequence of the promoter of the gene for the NADH-dependent nitrite reductase of Escherichia coli and its regulation by oxygen, the Fnr protein and nitrite. J. Mol. Biol. 196:781-788.
36. Jespersgaard, C., P. Zhang, G. Hajishengallis, M. W. Russell, and S. M. Michalek. 2001. Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein. Infect. Immun. 69:6604-6611.
37. Koesling, J., B. Lucas, L. Develioglou, T. Aebischer, and T. F. Meyer. 2001. Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy. Vaccine 20:413-420.
38. Kohler, J. J., L. B. Pathangey, S. R. Gillespie, and T. A. Brown. 2000. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin. Infect. Immun. 68:3116-3120.
39. Lasaro, M. O., W. B. Luiz, M. E. Sbrogio-Almeida, and L. C. Ferreira. 2005. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine 23:2430-2438.
40. Liu, W.-T., W.-T. Lin, C.-C. Tsai, C.-C. Chuang, C.-L. Liao, H.-C. Lin, Y.-W. Hung, S.-S. Huang, C.-C. Liang, H.-L. Hsu, H.-J. Wang, and Y.-T. Liu. 2006. Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge. Vaccine 24:5852-5861.
41. Londono-Arcila, P., D. Freeman, H. Kleanthous, A. M. O'Dowd, S. Lewis, A. K. Turner, E. L. Rees, T. J. Tibbitts, J. Greenwood, T. P. Monath, and M. J. Darsley. 2002. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect. Immun. 70:5096-5106.
42. + T cells in humans. Infect. Immun. 70:5622-5627.
43. McSorley, S. J., D. Xu, and F. Y. Liew. 1997. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infect. Immun. 65:171-178.
44. Menager, N., G. Foster, S. Ugrinovic, H. Uppington, S. Verbeek, and P. Mastroeni. 2007. Fcγ receptors are crucial for the expression of acquired resistance to virulent Salmonella enterica serovar Typhimurium in vivo but are not required for the induction of humoral or T-cell-mediated immunity. Immunology 120:424-432.
45. Metzger, W. G., E. Mansouri, M. Kronawitter, S. Diescher, M. Soerensen, R. Hurwitz, D. Bumann, T. Aebischer, B. U. Von Specht, and T. F. Meyer. 2004. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar Typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 22:2273-2277.
46. Orr, N., J. E. Galen, and M. M. Levine. 2001. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA. Vaccine 19:1694-1700.
47. Roberts, M., A. Bacon, J. Li, and S. Chatfield. 1999. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C. Infect. Immun. 67:3810-3815.
48. Russmann, H. 2003. Bacterial type III translocation: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella. Int. J. Med. Microbiol. 293:107-112.
49. Sevil Domenech, V. E., K. Panthel, K. M. Meinel, S. E. Winter, and H. Russmann. 2007. Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis. Microbes Infect. 9:1447-1453.
50. Sevil Domenech, V. E., K. Panthel, S. E. Winter, and H. Russmann. 2008. Heterologous prime-boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction. Vaccine 26:1879-1886.
51. Spreng, S., G. Dietrich, and G. Weidinger. 2006. Rational design of Salmonella-based vaccination strategies. Methods 38:133-143.
52. Spreng, S., and J. F. Viret. 2005. Plasmid maintenance systems suitable for GMO-based bacterial vaccines. Vaccine 23:2060-2065.
53. Stratford, R., N. D. McKelvie, N. J. Hughes, E. Aldred, C. Wiseman, J. Curtis, T. Bellaby, M. Bentley, Z. Hindle, F. R. Brennan, S. N. Chatfield, G. Dougan, and S. A. Khan. 2005. Optimization of Salmonella enterica serovar typhi -aroC -ssaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters. Infect. Immun. 73:362-368.
54. Strindelius, L., L. Degling Wikingsson, and I. Sjoholm. 2002. Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination. Infect. Immun. 70:1434-1442.
55. Strugnell, R. A., D. Maskell, N. Fairweather, D. Pickard, A. Cockayne, C. Penn, and G. Dougan. 1990. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88:57-63.
56. Terry, T. D., J. E. Downes, S. J. Dowideit, A. N. Mabbett, and M. P. Jennings. 2005. Investigation of ansB and sspA derived promoters for multi- and single-copy antigen expression in attenuated Salmonella enterica var. Typhimurium. Vaccine 23:4521-4531.
57. Uppington, H., N. Menager, P. Boross, J. Wood, M. Sheppard, S. Verbeek, and P. Mastroeni. 2006. Effect of immune serum and role of individual Fcγ receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages. Immunology 119:147-158.
58. Uren, T. K., O. L. Wijburg, C. Simmons, F. E. Johansen, P. Brandtzaeg, and R. A. Strugnell. 2005. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies. Eur. J. Immunol. 35:180-188.
59. Vindurampulle, C. J., and S. R. Attridge. 2003. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines. Infect. Immun. 71:287-297.
60. + mice. Infect. Immun. 71:2258-2261.
61. Wang, H. W., M. Zhang, J. Luan, W. J. Hu, P. Zhao, J. Gao, and Z. T. Qi. 2003. Antigen-expressed recombinant Salmonella typhimurium driven by an in vivo-activated promoter is capable of inducing cellular immune response in transgenic mice. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 35:695-701.
62. Whittle, B. L., and N. K. Verma. 1997. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. Vaccine 15:1737-1740.
63. Wyszynska, A., A. Raczko, M. Lis, and E. K. Jagusztyn-Krynicka. 2004. Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter. Vaccine 22:1379-1389.